December 16, 2010 | Charles River Laboratories plans seek "strategic alternatives" for two facilities: a Phase I research clinic in the U.S. and a pre-clinical research facility in China. The company expects that off-loading the two facilities to eliminate $10 million in losses. The company also announced a restructuring last month that is intended to reduce costs by $40 million in 2011. Mass High Tech